Published May 2019

The authors of the practice guideline seek to make recommendations, based on evidence identified from the systematic review, general principles of care, and related evidence, regarding the following questions: 1. In children and adults with TS or a chronic tic disorder, when should clinicians and pa

Published November 2016

This practice guideline addresses the following question: What are safe and effective therapies, including both pharmacologic and nonpharmacologic approaches, for the symptoms and clinical consequences (disturbed sleep, PLMS, depression/anxiety, and decreased QoL) of RLS in adults? Reaffirmed on Oc

Published April 2016

In 2008, the American Academy of Neurology (AAN) published guidelines on the uses of botulinum neurotoxin (BoNT). New research on 4 indications—blepharospasm, cervical dystonia (CD), spasticity, and headache—prompted this update. Reaffirmed on April 30, 2022. Endorsed by the American Association o

Published October 2011

Essential tremor (ET) is the most common tremor disorder and often affects activities of daily living, including writing and eating. This evidence-based guideline is an update of the 2005 American Academy of Neurology practice parameter on the treatment of essential tremor. Reaffirmed on July, 16,

Published January 2010

This article reviews and evaluates published evidence of the efficacy and safety of these medications in children and adolescents affected by spasticity due to CP. Reaffirmed on July 16, 2022.

Published May 2019

This article summarizes the findings of a systematic review, conducted as the foundation of an American Academy of Neurology (AAN) practice guideline on the treatment of tics in people with Tourette syndrome (TS) and chronic tic disorders. There is evidence to support the efficacy of various medical

Published November 2021

This practice guideline update includes conclusions and recommendations that address the efficacy and adverse effects of levodopa, dopamine agonists, and MAO-B inhibitors for treating motor symptoms of early Parkinson disease. Endorsed by the Parkinson's Foundation.